Bellevue Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-138
| Closed | -$1.21K | – | 466 |
|
|
2023
Q4 | $1.21K | Buy |
138
+45
| +48% | +$396 | ﹤0.01% | 445 |
|
|
2023
Q3 | $1.07K | Hold |
93
| – | – | ﹤0.01% | 446 |
|
|
2023
Q2 | $2.35K | Hold |
93
| – | – | ﹤0.01% | 388 |
|
|
2023
Q1 | $3K | Buy |
93
+17
| +22% | +$547 | ﹤0.01% | 370 |
|
|
2022
Q4 | $1.38K | Hold |
76
| – | – | ﹤0.01% | 447 |
|
|
2022
Q3 | $2K | Hold |
76
| – | – | ﹤0.01% | 448 |
|
|
2022
Q2 | $1K | Hold |
76
| – | – | ﹤0.01% | 494 |
|
|
2022
Q1 | $1K | Sell |
76
-16
| -17% | -$211 | ﹤0.01% | 529 |
|
|
2021
Q4 | $2K | Sell |
92
-7
| -7% | -$152 | ﹤0.01% | 526 |
|
|
2021
Q3 | $3K | Hold |
99
| – | – | ﹤0.01% | 486 |
|
|
2021
Q2 | $3K | Sell |
99
-9
| -8% | -$273 | ﹤0.01% | 484 |
|
|
2021
Q1 | $3K | Sell |
108
-15
| -12% | -$417 | ﹤0.01% | 544 |
|
|
2020
Q4 | $3K | Buy |
123
+56
| +84% | +$1.37K | ﹤0.01% | 558 |
|
|
2020
Q3 | $2K | Hold |
67
| – | – | ﹤0.01% | 579 |
|
|
2020
Q2 | $2K | Hold |
67
| – | – | ﹤0.01% | 573 |
|
|
2020
Q1 | $1K | Buy |
67
+34
| +103% | +$507 | ﹤0.01% | 596 |
|
|
2019
Q4 | $1K | Buy |
+33
| New | +$1K | ﹤0.01% | 531 |
|